London, UK/Newark, USA, September 14, 2012 — MakroCare, a global development and commercialization services company focused on partnering with Pharma, Biotech and Medical Devices firms to meet theit growth objectives, today announced that it has been selected as a finalist for the 2012 Scrip Awards in 2 categories – “Clinical Research Team of the Year” and “Best Technological Development in Clinical Trials”.
Criteria for selecting finalists in the “Clinical Research Team of the Year” category included an evaluation of scientific achievements from June 2011 to May 2012, impact on company performance, overcoming challenges and improving standards of research outside the organization.
MakroCare’s DDi subidiary’s product mPortal is also nominated for an award in the “Best Technological Development in Clinical Trials” category. mPortal enables development teams, sites and all other partners /stake holders collaborate and share information as well as documents securely with online interfaces. mPortal’s main objective was to keep systems simple to use as that will accelerate the adoption as well as acceptance of intended users. As all information sharing in future is bound to happen online and hand held devices, having effective clinical technologies in that direction will decrease costs, increase virtual team collaborations and productivity.
Mr. Mahesh Malneedi said, “We’re excited about the judges’ recognition of DDi, a MakroCare subsidiary, unique ability to bring different stake holders and partners in a complex drug development environment with a simple yet comprehensive collaboration platform. And I am happy that my teams got recognized for their efforts in clinical research who are ensuring their part to have patients receive much needed new cures faster.”
The prestigious 8th Annual SCRIP Awards are sponsored by SCRIP Clinical Research Journal, and published by Informa Healthcare. The SCRIP Awards give the international pharmaceutical community an opportunity to acknowledge and applaud its highest achievers across the value chain, and recognize both corporate and individual achievement. Entries to the awards are nominated by members of the pharmaceutical industry. A panel of highly respected and independent luminaries from across the sector will choose the winners for each category. In November, the 2012 winners will be announced at a gala dinner in London.
MakroCare is a USA head quartered multidisciplinary development, consulting and commercialization global firm that supports pharmaceutical, biotechnology, and medical device industries. MakroCare has 5 main divisions – Consulting, CRO, SMO, DDi(Informatics), and Commercialization. Through these focused divisions, it offers global consulting, regulatory affairs, risk management, site selection, patient recruitment, trial management (P II/III and late phase), clinical affairs, biometrics, safety/pv, informatics(eClinical products, solutions), medical affairs, bpo and call center services. These services are provided from various offices in USA, UK, Europe and Asia.